rs79008179

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003719.5(PDE8B):​c.1366-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0283 in 1,609,390 control chromosomes in the GnomAD database, including 772 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 49 hom., cov: 32)
Exomes 𝑓: 0.029 ( 723 hom. )

Consequence

PDE8B
NM_003719.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00005541
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.416

Publications

6 publications found
Variant links:
Genes affected
PDE8B (HGNC:8794): (phosphodiesterase 8B) The protein encoded by this gene is a cyclic nucleotide phosphodiesterase (PDE) that catalyzes the hydrolysis of the second messenger cAMP. The encoded protein, which does not hydrolyze cGMP, is resistant to several PDE inhibitors. Defects in this gene are a cause of autosomal dominant striatal degeneration (ADSD). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2010]
PDE8B Gene-Disease associations (from GenCC):
  • autosomal dominant striatal neurodegeneration type 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pigmented nodular adrenocortical disease, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • primary pigmented nodular adrenocortical disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • striatal degeneration, autosomal dominant
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-77408888-G-A is Benign according to our data. Variant chr5-77408888-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 354162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0242 (3687/152268) while in subpopulation NFE AF = 0.0334 (2272/68034). AF 95% confidence interval is 0.0323. There are 49 homozygotes in GnomAd4. There are 1757 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3687 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDE8BNM_003719.5 linkc.1366-5G>A splice_region_variant, intron_variant Intron 13 of 21 ENST00000264917.10 NP_003710.1 O95263-1B3KN77

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDE8BENST00000264917.10 linkc.1366-5G>A splice_region_variant, intron_variant Intron 13 of 21 1 NM_003719.5 ENSP00000264917.6 O95263-1
PDE8BENST00000646262.1 linkc.994-5G>A splice_region_variant, intron_variant Intron 15 of 23 ENSP00000493971.1 A0A2R8Y4E6

Frequencies

GnomAD3 genomes
AF:
0.0242
AC:
3689
AN:
152150
Hom.:
49
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0192
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0105
Gnomad ASJ
AF:
0.0202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00394
Gnomad FIN
AF:
0.0286
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0334
Gnomad OTH
AF:
0.0138
GnomAD2 exomes
AF:
0.0224
AC:
5622
AN:
251310
AF XY:
0.0224
show subpopulations
Gnomad AFR exome
AF:
0.0199
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.0199
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0309
Gnomad NFE exome
AF:
0.0342
Gnomad OTH exome
AF:
0.0235
GnomAD4 exome
AF:
0.0287
AC:
41854
AN:
1457122
Hom.:
723
Cov.:
30
AF XY:
0.0281
AC XY:
20396
AN XY:
725272
show subpopulations
African (AFR)
AF:
0.0191
AC:
639
AN:
33390
American (AMR)
AF:
0.00747
AC:
334
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0201
AC:
526
AN:
26112
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39676
South Asian (SAS)
AF:
0.00530
AC:
457
AN:
86162
European-Finnish (FIN)
AF:
0.0327
AC:
1745
AN:
53398
Middle Eastern (MID)
AF:
0.0213
AC:
123
AN:
5764
European-Non Finnish (NFE)
AF:
0.0330
AC:
36564
AN:
1107666
Other (OTH)
AF:
0.0243
AC:
1463
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1764
3529
5293
7058
8822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1292
2584
3876
5168
6460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0242
AC:
3687
AN:
152268
Hom.:
49
Cov.:
32
AF XY:
0.0236
AC XY:
1757
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0191
AC:
793
AN:
41552
American (AMR)
AF:
0.0105
AC:
161
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
70
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4818
European-Finnish (FIN)
AF:
0.0286
AC:
303
AN:
10598
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0334
AC:
2272
AN:
68034
Other (OTH)
AF:
0.0137
AC:
29
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
189
378
567
756
945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
63
Bravo
AF:
0.0235
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency. Insufficient evidence for gene-disease association. -

Autosomal dominant striatal neurodegeneration type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

PDE8B-related disorder Benign:1
Sep 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.4
DANN
Benign
0.65
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79008179; hg19: chr5-76704713; API